X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Orchid Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs ORCHID PHARMA LTD - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD ORCHID PHARMA LTD STRIDES SHASUN LTD/
ORCHID PHARMA LTD
 
P/E (TTM) x 14.0 -0.8 - View Chart
P/BV x 1.9 0.6 338.1% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 STRIDES SHASUN LTD   ORCHID PHARMA LTD
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-16
ORCHID PHARMA LTD
Sep-13
STRIDES SHASUN LTD/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs1,413194 728.1%   
Low Rs84835 2,422.9%   
Sales per share (Unadj.) Rs353.3276.5 127.8%  
Earnings per share (Unadj.) Rs23.4-79.2 -29.5%  
Cash flow per share (Unadj.) Rs41.0-43.5 -94.3%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs320.453.9 594.1%  
Shares outstanding (eoy) m89.3570.45 126.8%   
Bonus/Rights/Conversions ESOPESOP-  
Price / Sales ratio x3.20.4 772.5%   
Avg P/E ratio x48.3-1.4 -3,343.6%  
P/CF ratio (eoy) x27.6-2.6 -1,046.4%  
Price / Book Value ratio x3.52.1 166.2%  
Dividend payout %21.40-   
Avg Mkt Cap Rs m100,9888,067 1,251.9%   
No. of employees `0004.72.8 167.5%   
Total wages/salary Rs m4,9882,527 197.4%   
Avg. sales/employee Rs Th6,730.06,956.1 96.7%   
Avg. wages/employee Rs Th1,063.6902.5 117.9%   
Avg. net profit/employee Rs Th445.5-1,993.0 -22.4%   
INCOME DATA
Net Sales Rs m31,56419,477 162.1%  
Other income Rs m1,212407 297.7%   
Total revenues Rs m32,77619,884 164.8%   
Gross profit Rs m5,2131,103 472.8%  
Depreciation Rs m1,5732,519 62.4%   
Interest Rs m1,8035,227 34.5%   
Profit before tax Rs m3,049-6,236 -48.9%   
Minority Interest Rs m12720 642.6%   
Prior Period Items Rs m-270-   
Extraordinary Inc (Exp) Rs m-371511 -72.6%   
Tax Rs m689-125 -550.0%   
Profit after tax Rs m2,089-5,580 -37.4%  
Gross profit margin %16.55.7 291.7%  
Effective tax rate %22.62.0 1,124.8%   
Net profit margin %6.6-28.7 -23.1%  
BALANCE SHEET DATA
Current assets Rs m35,94911,014 326.4%   
Current liabilities Rs m19,40232,060 60.5%   
Net working cap to sales %52.4-108.1 -48.5%  
Current ratio x1.90.3 539.3%  
Inventory Days Days7195 74.7%  
Debtors Days Days12734 377.9%  
Net fixed assets Rs m34,47829,440 117.1%   
Share capital Rs m894705 126.8%   
"Free" reserves Rs m22,6012,043 1,106.5%   
Net worth Rs m28,6323,800 753.5%   
Long term debt Rs m27,4559,018 304.4%   
Total assets Rs m76,59146,510 164.7%  
Interest coverage x2.7-0.2 -1,393.5%   
Debt to equity ratio x1.02.4 40.4%  
Sales to assets ratio x0.40.4 98.4%   
Return on assets %5.1-0.8 -668.7%  
Return on equity %7.3-146.9 -5.0%  
Return on capital %8.2-3.7 -218.7%  
Exports to sales %48.137.9 127.1%   
Imports to sales %14.522.6 63.9%   
Exports (fob) Rs m15,1927,378 205.9%   
Imports (cif) Rs m4,5654,406 103.6%   
Fx inflow Rs m16,6127,513 221.1%   
Fx outflow Rs m5,2925,649 93.7%   
Net fx Rs m11,3201,865 607.1%   
CASH FLOW
From Operations Rs m7171,682 42.6%  
From Investments Rs m-22,284-9,860 226.0%  
From Financial Activity Rs m29,4886,644 443.8%  
Net Cashflow Rs m8,073-1,535 -525.9%  

Share Holding

Indian Promoters % 27.7 32.3 85.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.8 4.6 821.7%  
FIIs % 8.6 3.3 260.6%  
ADR/GDR % 0.0 4.6 -  
Free float % 25.9 55.3 46.8%  
Shareholders   56,241 84,811 66.3%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   IPCA LABS  SANOFI INDIA  ALEMBIC PHARMA  MERCK LTD  NOVARTIS  

Compare STRIDES SHASUN LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Aug 18, 2017 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 5-YR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS